Pac-Link logo

Pac-Link

Asia, T'ai-pei, Taiwan, Taipei

Description

Pac-Link is a venture capital firm.

Investor Profile

Pac-Link has backed more than 15 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 13% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series D rounds (top funding stages).
  • Majority of deals are located in United States, China, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series B (33%)
  • Series Unknown (20%)
  • Series D (20%)
  • Series C (13%)
  • Series G (7%)
  • Series F (7%)

Country Focus

  • United States (87%)
  • China (7%)
  • Canada (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma
  • Wireless
  • Medical Device
  • Oncology
  • Pharmaceutical
  • Telecommunications
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pac-Link frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 3
JAIC America
North America, California, United States, Palo Alto
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
BL
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 2
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Menlo Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
SightLine Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
Advanced Technology Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 3

Which angels does Pac-Link often collaborate with?

David Lee
Asia, T'ai-pei, Taiwan, Taipei
Shared Deals: 1

What are some of recent deals done by Pac-Link?

Revance Therapeutics

Newark, California, United States

Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DJun 10, 2011
Amount Raised: $45,000,000
Synerchip

Sunnyvale, California, United States

Synerchip, a semiconductor company, developed high-speed digital interface technology for consumer electronic networks.

Consumer ElectronicsSemiconductorVideo
Series CApr 20, 2010
Amount Raised: $10,500,000
Revance Therapeutics

Newark, California, United States

Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DDec 28, 2009
Amount Raised: $25,620,000
Broncus Technologies

Mountain View, California, United States

Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.

BiotechnologyHealth CareMedicalMedical Device
Series GDec 5, 2008
Amount Raised: $38,000,000
UltiZen

Shanghai, Shanghai, China

Ultizen Games is a game development and offshore game outsourcing company in China, offering online, PC, Xbox360 live and arcade games.

Developer APIsOutsourcingPC Games
Series BAug 5, 2008
Amount Raised: $6,000,000
Portola Pharmaceuticals

South San Francisco, California, United States

Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.

BiopharmaBiotechnologyTherapeutics
Series CJul 1, 2008
Amount Raised: $60,099,999
Serenex

Durham, North Carolina, United States

Serenex is a drug discovery and development company focused on oncology.

BiotechnologyHealth CareMedicalOncology
Series DJun 28, 2007
Amount Raised: $26,000,000
DiObex

San Francisco, California, United States

DiObex develops novel products for the treatment of metabolic disorders.

BiotechnologyHealth CareMedical
Series BApr 16, 2007
Amount Raised: $24,000,000
Trellis Bioscience

San Francisco, California, United States

Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.

BiotechnologyHealth CareOncologyTherapeutics
Series BFeb 14, 2007
Amount Raised: $10,000,000
Broncus Technologies

Mountain View, California, United States

Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.

BiotechnologyHealth CareMedicalMedical Device
Series FSep 1, 2006
Amount Raised: $29,500,000